Yan Siyu, Bi Youkun, Liu Qun, Song Shaole, Ma Lihong, Ji Guangju
Chinese Academy of Medical Sciences & Peking Union Medical College Fuwai Hospital, Beijing, China.
Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Stem Cell Rev Rep. 2025 Apr;21(3):834-848. doi: 10.1007/s12015-024-10840-1. Epub 2025 Jan 28.
The hypobaric hypoxic atmosphere can cause adverse reactions or sickness. The purpose of this study was to explore the preventive effect and mechanism of human umbilical cord mesenchymal stem cells (hUC-MSCs) on acute pathological injury in mice exposed to high-altitude.
We pretreated C57BL/6 mice with hUC-MSCs via the tail vein injection, and then the mice were subjected to hypobaric hypoxic conditions for five days. The effects of hUC-MSCs on the pathological injury of lung, heart, brain were assessed by biochemical analysis, histopathological testing, quantitative real-time polymerase chain reaction (qPCR), and western blot (WB). Further, transcriptome sequencing was used to screen for the potential therapeutic targets of hUC-MSCs in acute pathological injury, the identified signaling axis was characterized using Apoe mice, qPCR and WB.
hUC-MSCs administration notably prevented and relieved gastrointestinal symptoms and inflammation of lung and heart, increased blood oxygen saturation and serum superoxide dismutase (SOD) level, decreased serum malondialdehyde (MDA) level, rescued lung tissue injury and myocardial mitochondrial disorder, elevated nissl bodies number in brain tissue and reduced the degree of pulmonary and cerebral edema. Furthermore, hUC-MSCs pretreatment reversed the down-regulated Apoe and up-regulated Pdgf-b and p-Erk1/2 in the lung of hypobaric hypoxic mice. Thus, hUC-MSCs protected against acute pathological injury caused by hypobaric hypoxic condition via the Apoe/Pdgf-b/p-Erk1/2 axis, and the identified pathway was confirmed by the negative results of Apoe mice.
hUC-MSCs possess the preventive effect on acute pathological injury caused by hypobaric hypoxia environment at high-altitude.
低压低氧环境可导致不良反应或疾病。本研究旨在探讨人脐带间充质干细胞(hUC-MSCs)对高原暴露小鼠急性病理损伤的预防作用及机制。
通过尾静脉注射用hUC-MSCs预处理C57BL/6小鼠,然后将小鼠置于低压低氧条件下5天。通过生化分析、组织病理学检测、定量实时聚合酶链反应(qPCR)和蛋白质免疫印迹法(WB)评估hUC-MSCs对肺、心脏、脑病理损伤的影响。此外,利用转录组测序筛选hUC-MSCs在急性病理损伤中的潜在治疗靶点,使用载脂蛋白E(Apoe)小鼠、qPCR和WB对鉴定出的信号轴进行表征。
给予hUC-MSCs显著预防和缓解了胃肠道症状以及肺和心脏的炎症,提高了血氧饱和度和血清超氧化物歧化酶(SOD)水平,降低了血清丙二醛(MDA)水平,挽救了肺组织损伤和心肌线粒体紊乱,增加了脑组织中尼氏体数量,减轻了肺水肿和脑水肿程度。此外,hUC-MSCs预处理逆转了低压低氧小鼠肺中Apoe的下调以及血小板衍生生长因子B(Pdgf-b)和磷酸化细胞外信号调节激酶1/2(p-Erk1/2)的上调。因此,hUC-MSCs通过Apoe/Pdgf-b/p-Erk1/2轴保护小鼠免受低压低氧条件引起的急性病理损伤,且Apoe小鼠的阴性结果证实了所鉴定的通路。
hUC-MSCs对高原低压低氧环境引起的急性病理损伤具有预防作用。